1. Adiponectin-Resistance in Obesity
    Atilla Engin, 2017 CrossRef
  2. Bergamottin Promotes Adipocyte Differentiation and Inhibits Tumor Necrosis Factor-α-induced Inflammatory Cytokines Induction in 3T3-L1 Cells
    Hideya Mizuno et al, 2017, YAKUGAKU ZASSHI CrossRef
  3. γ-tocotrienol attenuates TNF-α-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes
    TETSURO MATSUNAGA et al, 2012 CrossRef
  4. Neuroprotectant androst-3β, 5α, 6β-triol suppresses TNF-α-induced endothelial adhesion molecules expression and neutrophil adhesion to endothelial cells by attenuation of CYLD-NF-κB pathway.
    Min Yan et al, 2017, Biochem Biophys Res Commun CrossRef
  5. Effects of clozapine on adipokine secretions/productions and lipid droplets in 3T3-L1 adipocytes.
    Tomomi Tsubai et al, 2017, J Pharmacol Sci CrossRef
  6. Mesenteric Adipocyte Dysfunction in Crohnʼs Disease is Associated with Hypoxia
    Lugen Zuo et al, 2016, Inflammatory Bowel Diseases CrossRef
  7. L-4F Inhibits Oxidized Low-density Lipoprotein-induced Inflammatory Adipokine Secretion via Cyclic AMP/Protein Kinase A-CCAAT/Enhancer Binding Protein β Signaling Pathway in 3T3-L1 Adipocytes.
    Xiang-Zhu Xie et al, 2016, Chin Med J (Engl) CrossRef
  8. Forskolin Inhibits Lipopolysaccharide-Induced Modulation of MCP-1 and GPR120 in 3T3-L1 Adipocytes through an Inhibition of NFκB.
    Jeanne Durendale Chiadak et al, 2016, Mediators Inflamm CrossRef
  9. Emerging role of adipokines as mediators in atherosclerosis
    Hanrui Zhang, 2010, WJC CrossRef
  10. Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders
    Mayur Doke et al, 2018, BioMed Research International CrossRef
  11. Weight loss is a critical factor to reduce inflammation
    Vittorio Emanuele Bianchi, 2018, Clinical Nutrition ESPEN CrossRef
  12. Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus
    Maggie S. Burhans et al, 2018 CrossRef
  13. Inhibitory Effects of Rosiglitazone on Lipopolysaccharide-Induced Inflammation in a Murine Model and HK-2 Cells
    W.M. Wang et al, 2011, Am J Nephrol CrossRef
  14. Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies
    Amrita Banerjee et al, 2019, Bioeng Transl Med CrossRef
  15. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
    Alan Chait et al, 2020, Front. Cardiovasc. Med. CrossRef
  16. Treatment of insulin resistance in obesity-associated type 2 diabetes mellitus through adiponectin gene therapy
    Amrita Banerjee et al, 2020, International Journal of Pharmaceutics CrossRef
  17. Uric acid upregulates the adiponectin‑adiponectin receptor�1 pathway in renal proximal tubule epithelial cells
    Qingmei Yang et al, 2017, Mol Med Report CrossRef
  18. Phenotypic Shift of Adipocytes by Cholecalciferol and 1α,25 Dihydroxycholecalciferol in Relation to Inflammatory Status and Calcium Content
    Elena Zoico et al, 2014 CrossRef
  19. SUMO1 Deficiency Exacerbates Neurological and Cardiac Dysfunction after Intracerebral Hemorrhage in Aged Mice.
    Wei Li et al, 2021, Transl Stroke Res CrossRef
  20. Protective Role of St. John's Wort and Its Components Hyperforin and Hypericin against Diabetes through Inhibition of Inflammatory Signaling: Evidence from In Vitro and In Vivo Studies.
    Michela Novelli et al, 2020, Int J Mol Sci CrossRef
  21. How does adipose tissue contribute to inflammageing?
    Mauro Zamboni et al, 2021, Experimental Gerontology CrossRef
  22. Pioglitazone Inhibits Periprostatic White Adipose Tissue Inflammation in Obese Mice
    Miki Miyazawa et al, 2018, Cancer Prev Res CrossRef
  23. The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
    Aldo Grefhorst et al, 2021, Front. Endocrinol. CrossRef
  24. On the Immunometabolic Role of NF-кB in Adipocytes
    , 2022, Immunometabolism CrossRef
  25. Searching for the link between inflammaging and sarcopenia
    Tiantian Wang, 2022, Ageing Research Reviews CrossRef
  26. IL-25 directly modulates adipocyte function and inflammation through the regulation of adiponectin
    Siranart Jeerawattanawart et al, 2022, Inflamm. Res. CrossRef
  27. 7. The role of diet in systemic and neural inflammation in obesity and metabolic syndrome
    D.C.L. Masquio et al, 2017 CrossRef
  28. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes
    Pere Domingo et al, 2022, Life Sciences CrossRef
  29. Familial partial lipodystrophy type 2 and obesity, two adipose tissue pathologies with different inflammatory profiles
    Guillaume Treiber et al, 2023, Diabetol Metab Syndr CrossRef
  30. Non-alcoholic fatty liver disease and obesity: Biochemical, metabolic and clinical presentations
    Sandra Milić, 2014, WJG CrossRef
  31. Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction
    Atilla Engin, 2024 CrossRef
  32. Evaluating Pro- and Anti-inflammatory Biomarkers for Predicting Type 2 Diabetes Mellitus in the Geriatric Population and Correlation With Clinical and Biochemical Parameters
    Sartaj Hussain et al, 2025 CrossRef